Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.
The present study was aimed at formulating tablets comprising of coating susceptible to microbial enzyme degradation for releasing budesonide in the colon. Tablets prepared by using Avicel pH 102 as diluent and Eudragit L100-55 as binder were coated to a weight gain of 10% w/w employing aqueous mixtures containing chitosan (CH) and chondroitin sulfate (CS). The interpolymer complex between CH and CS was characterized using Fourier transform infrared (FTIR) and differential scanning calorimetery (DSC) studies. The tablets were evaluated for release of budesonide through in vitro in vivo studies. Formation of bonds between -COO(-) and -OSO3(-) groups of CS and -NH3+ groups of CH was evident in the FTIR spectra of these interpolymer complexed (IPC) films. The DSC thermograms of these films revealed one endothermic transition between 190 degrees C and 205 degrees C, suggesting the formation of new bonds in the IPC. The pH sensitive swelling exhibited by these films was observed to be a function of CH concentration. Tablets coated with aqueous mixtures containing 40:60 or 50:50 ratio of CH/CS totally prevented the release of budesonide in pH 1.2 buffer. The peaks (FTIR) and endothermic transitions (DSC) characteristic of interpolymer complexation were observed to remain unaffected after sequential exposure of the films to pH 1.2 and pH 7.4 buffer IP. This proved the versatility of these IPC films for colon delivery. C (max) of 1,168.99 and 1,174.2 ng/mL, respectively, at 12 and 8 h post-oral dosing of tablets coated with 40:60 or 50:50 ratio of CH/CS was observed in rats. The aqueous CH/CS (40:60) coating could provide a facile method for delivering budesonide to the colon.
Kaur
Gurpreet
G
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India.
Rana
Vikas
V
Jain
Subheet
S
Tiwary
Ashok K
AK
D000180:Acrylic Resins; D000818:Animals; D019819:Budesonide / Q000378:metabolism; D048271:Chitosan / Q000737:chemistry* / Q000378:metabolism; D002807:Chondroitin / Q000378:metabolism; D002809:Chondroitin Sulfates / Q000378:metabolism; D003106:Colon / Q000378:metabolism*; D005079:Excipients / Q000737:chemistry / Q000378:metabolism; D005260:Female; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013607:Tablets; D014867:Water / Q000378:metabolism
D000180:Acrylic Resins; C446821:Eudragit L100-55; D005079:Excipients; D013607:Tablets; C480355:chitosan sulfate; D014867:Water; D019819:Budesonide; D002807:Chondroitin; D002809:Chondroitin Sulfates; D048271:Chitosan